344 related articles for article (PubMed ID: 33754039)
41. Glycometabolic reprogramming-mediated proangiogenic phenotype enhancement of cancer-associated fibroblasts in oral squamous cell carcinoma: role of PGC-1α/PFKFB3 axis.
Li X; Jiang E; Zhao H; Chen Y; Xu Y; Feng C; Li J; Shang Z
Br J Cancer; 2022 Aug; 127(3):449-461. PubMed ID: 35444287
[TBL] [Abstract][Full Text] [Related]
42. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
[TBL] [Abstract][Full Text] [Related]
43. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of miR-7 promotes angiogenesis in human umbilical vein endothelial cells by upregulating VEGF via KLF4.
Li YZ; Wen L; Wei X; Wang QR; Xu LW; Zhang HM; Liu WC
Oncol Rep; 2016 Sep; 36(3):1569-75. PubMed ID: 27431648
[TBL] [Abstract][Full Text] [Related]
45. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
46. Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis.
Dong H; Yang C; Chen X; Sun H; He X; Wang W
Breast Cancer; 2023 Nov; 30(6):1028-1040. PubMed ID: 37653187
[TBL] [Abstract][Full Text] [Related]
47. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
[TBL] [Abstract][Full Text] [Related]
48. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.
Yu W; Chai H; Li Y; Zhao H; Xie X; Zheng H; Wang C; Wang X; Yang G; Cai X; Falck JR; Yang J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):73-83. PubMed ID: 22841774
[TBL] [Abstract][Full Text] [Related]
52. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
[TBL] [Abstract][Full Text] [Related]
53. Control of VEGF expression in triple-negative breast carcinoma cells by suppression of SAF-1 transcription factor activity.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2011 Aug; 9(8):1030-41. PubMed ID: 21665940
[TBL] [Abstract][Full Text] [Related]
54. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
55. p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth.
Hayashi Y; Tsujii M; Kodama T; Akasaka T; Kondo J; Hikita H; Inoue T; Tsujii Y; Maekawa A; Yoshii S; Shinzaki S; Watabe K; Tomita Y; Inoue M; Tatsumi T; Iijima H; Takehara T
Carcinogenesis; 2016 Oct; 37(10):972-984. PubMed ID: 27520561
[TBL] [Abstract][Full Text] [Related]
56. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling.
Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
Oncotarget; 2016 Jun; 7(26):40148-40159. PubMed ID: 27223086
[TBL] [Abstract][Full Text] [Related]
57. Xanthorrhizol Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Modulating Akt/eNOS Signaling and the NF-[Formula: see text]B-Dependent Expression of Cell Adhesion Molecules.
Lee SK; Kim MJ; Son SH; Kim KR; Park KK; Chung WY
Am J Chin Med; 2021; 49(3):737-751. PubMed ID: 33683188
[TBL] [Abstract][Full Text] [Related]
58. p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
Al-Ansari MM; Hendrayani SF; Tulbah A; Al-Tweigeri T; Shehata AI; Aboussekhra A
Neoplasia; 2012 Dec; 14(12):1269-77. PubMed ID: 23308058
[TBL] [Abstract][Full Text] [Related]
59. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.
Watanabe K; Shiga K; Maeda A; Harata S; Yanagita T; Suzuki T; Ushigome H; Maeda Y; Hirokawa T; Ogawa R; Hara M; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913066
[TBL] [Abstract][Full Text] [Related]
60. Erratum: FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts: Erratum.
Wan X; Guan S; Hou Y; Qin Y; Zeng H; Yang L; Qiao Y; Liu S; Li Q; Jin T; Qiu Y; Liu M
Theranostics; 2022; 12(14):6157-6158. PubMed ID: 36168614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
